Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
Talc: Hydrated magnesium silicate is restricted in cosmetic products under Annex III of the EU Cosmetics Regulation (EC) 1223/2009.
Concern score
The concern value reflects this ingredient's chemical identity — its hazard profile from the published classifications and regulatory status below — not the safety of a product it appears in. A score near 40 is the baseline for ingredients with no specific signal (water scores 40 by design), so a mid-range value is not a safety verdict.
Concern score 70/100 (high) · high confidence.
Regional restrictions
Prevalence of TALC in our catalog (epa_cpdat).
Products
13,323
Brands
6
Typical roles
Catalog
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
The published evidence profile currently shaping this ingredient record.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
EU
EC
Annex III of EU Cosmetics Regulation (EC) 1223/2009: substances which cosmetic products must not contain except subject to the restrictions laid down. Product types: (a) Powdery products intended to be used for children under 3 years of age (b) Other products Conditions of use and warnings: (a) Keep powder away from children's nose and mouth
US
EPA
EPA CPDat observed this chemical in 13323 composition records across product categories including Construction and building materials, Raw materials, Furniture and furnishings. EPA CPDat classifies this chemical for functional uses including Abrasive, Absorbent, Volumizing Agent.
Déo-soin 24h
Léa Nature
US
FDA
Route: BUCCAL; Dosage form: GUM, CHEWING; Potency: NA
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 729 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, COATED; Maximum daily exposure: 87 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, COATED PELLETS; Potency: 14 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, COATED, EXTENDED RELEASE; Maximum daily exposure: 20 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 420 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 5119 mg
US
FDA
Route: ORAL; Dosage form: GRANULE; Maximum daily exposure: 322 mg
US
FDA
Route: ORAL; Dosage form: GRANULE, DELAYED RELEASE; Maximum daily exposure: 525 mg
US
FDA
Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Maximum daily exposure: 296 mg
US
FDA
Route: ORAL; Dosage form: LOZENGE; Maximum daily exposure: 50 mg
US
FDA
Route: ORAL; Dosage form: PELLET; Maximum daily exposure: 69 mg
US
FDA
Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 735 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 234 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION, EXTENDED RELEASE; Maximum daily exposure: 46 mg
US
FDA
Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 202 mg
US
FDA
Route: ORAL; Dosage form: TABLET, CHEWABLE, EXTENDED RELEASE; Maximum daily exposure: 18 mg
US
FDA
Route: ORAL; Dosage form: TABLET, COATED; Potency: 320.75 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 349 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE PARTICLES; Maximum daily exposure: 56 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 300 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 91 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED, EXTENDED RELEASE; Maximum daily exposure: 60 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FOR SUSPENSION; Maximum daily exposure: 24 mg
US
FDA
Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 80 mg
US
FDA
Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE; Maximum daily exposure: 357 mg
US
FDA
Route: ORAL; Dosage form: TABLET, SUGAR COATED; Potency: NA
US
FDA
Route: SUBLINGUAL; Dosage form: TABLET; Potency: 32.4 mg
US
FDA
Route: TOPICAL; Dosage form: OINTMENT; Potency: 74.6 %w/w
US
FDA
Route: TOPICAL; Dosage form: POWDER; Maximum daily exposure: 9235 mg
US
FDA
FDA NDC lists this ingredient in 4 active drug products and 4 total products.
US
FDA
openFDA substance registry classifies this ingredient as concept.
US
FDA
openFDA substance registry classifies this ingredient as chemical.